Lanzhou Foci Pharmaceutical Co., Ltd.(002644.SZ)
Profile
Registered Capital:
80.78(RMB MLN)
Employees:
1428
WebSite:
http://www.fczy.com
Lanzhou Foci Pharmaceutical Co., Ltd. is principally engaged in the research, development, manufacture and distribution of Chinese patent medicines. The Company provides pills, tablets, granules, capsules, powders, oral liquid, syrup and vinum, among others. Its products are 191 over the counter (OTC) and 271 receptor medicines, including Liuwei Dihuang Pills, Xiaoyao Pills, Guifu Dihuang Pills, Zhibai Dihuang Pills, Shenrong Guben Huanshao Pills, Xiangsha Yangwei Pills, Lycii and Chrysanthemi and Rehmanniae Bolus, Buzhong Yiqi Pills, Spleen-tonyfying Pills, Tianwang Buxin Pills, Mingmu Diuang Pills, Ercong Zuoci Pills, Baohe Pills, Giant-hyssop Pills, Anshen Buxin Pills, Danggui Pills and Jianpi Pills, among others.
Reports